Captan

Captan

SCHEMBL2988537

O=C1C2CC=CCC2C(=O)N1SC(Cl)(Cl)Cl.OCCO

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.86
LMNA P02545 3/20 0.86
TP53 P04637 3/20 0.86
TSHR P16473 2/20 0.86
KMT2A Q03164 2/20 0.86
HSD17B10 Q99714 2/20 0.86
CYP3A4 P08684 1/20 0.86
HPGD P15428 1/20 0.86
ALOX15 P16050 1/20 0.86
MAPK1 P28482 1/20 0.86
HTT P42858 1/20 0.86
HIF1A Q16665 1/20 0.86
CA9 Q16790 3/20 0.35
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
TDP1 Q9NUW8 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Captan SCHEMBL11862934 0.93 ALDH1A1 (1.00) ALDH1A1LMNATP53TSHRKMT2A
Captan SCHEMBL5361742 0.93 ALDH1A1 (1.00) ALDH1A1LMNATP53TSHRKMT2A
Captan SCHEMBL21047 0.93 ALDH1A1 (1.00) ALDH1A1LMNATP53TSHRKMT2A
Captan SCHEMBL11229310 0.93 ALDH1A1 (1.00) ALDH1A1LMNATP53TSHRKMT2A
Captan SCHEMBL2121611 0.93 ALDH1A1 (1.00) ALDH1A1LMNATP53TSHRKMT2A
Captan SCHEMBL9671681 0.91 ALDH1A1 (0.96) ALDH1A1LMNATP53TSHRKMT2A
Captan SCHEMBL1765903 0.91 ALDH1A1 (0.96) ALDH1A1LMNATP53TSHRKMT2A
Captan SCHEMBL9314863 0.91 ALDH1A1 (0.96) ALDH1A1LMNATP53TSHRKMT2A
Captan SCHEMBL2474650 0.86 ALDH1A1 (0.73) ALDH1A1LMNATP53TSHRKMT2A
Captan SCHEMBL4293213 0.82 ALDH1A1 (0.78) ALDH1A1LMNATP53TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240009206-A1 Steroidal Compositions LIPOCINE INC. (US) 2024-01-11 US disclosed
US-11052096-B2 Steroidal compositions LIPOCINE INC. (US) 2021-07-06 US disclosed
US-20210177865-A1 Steroidal Compositions LIPOCINE INC. (US) 2021-06-17 US disclosed
US-20210100816-A1 Steroidal Compositions LIPOCINE INC. (US) 2021-04-08 US disclosed
US-20210038615-A1 Steroidal Compositions LIPOCINE INC. (US) 2021-02-11 US disclosed
US-20200390785-A1 Liver Disease LIPOCINE INC. (US) 2020-12-17 US disclosed
US-20200383998-A1 Liver Disease LIPOCINE INC. (US) 2020-12-10 US disclosed
US-20200383999-A1 STEROIDAL COMPOSITIONS LIPOCINE INC. (US) 2020-12-10 US disclosed
US-20200155570-A1 LIVER DISEASE LIPOCINE INC. (US) 2020-05-21 US disclosed
US-20170354663-A1 Steroidal Compositions LIPOCINE INC. (US) 2017-12-14 US disclosed
US-20170252357-A1 Steroidal Compositions LIPOCINE INC. (US) 2017-09-07 US disclosed
US-20170216312-A1 STERODIAL COMPOSITIONS LIPOCINE INC. (US) 2017-08-03 US disclosed
EP-3078368-A1 STEROIDAL COMPOSITIONS Lipocine Inc. (US) 2016-10-12 EP disclosed
US-8865695-B2 Steroidal compositions LIPOCINE INC. (US) 2014-10-21 US disclosed
US-8778922-B2 Steroidal compositions LIPOCINE INC. (US) 2014-07-15 US disclosed
US-20140178466-A1 Steroidal Compositions LIPOCINE INC. (US) 2014-06-26 US disclosed
US-20140179652-A1 Steroidal Compositions LIPOCINE INC. (US) 2014-06-26 US disclosed
US-20120322780-A1 STEROIDAL COMPOSITIONS LIPOCINE, INC. (US) 2012-12-20 US disclosed
US-20100173882-A1 Steroidal Compositions LIPOCINE, INC. (US) 2010-07-08 US disclosed
US-6569463-B2 Encapsulation coat includes different combinations of pharmaceutical active ingredients, hydrophilic and lipophilic surfactants, and triglycerides LIPOCINE, INC. 2003-05-27 US disclosed